USA Financial Formulas’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$800 Hold
3
﹤0.01% 349
2025
Q4
$753 Sell
3
-2,676
-100% -$711K ﹤0.01% 333
2025
Q3
$769K Buy
2,679
+59
+2% +$15.8K 0.14% 58
2025
Q2
$688K Sell
2,620
-459
-15% -$112K 0.12% 78
2025
Q1
$717K Buy
+3,079
New +$747K 0.12% 74
2022
Q1
Sell
-2
Closed -$1K 432
2021
Q4
$1K Sell
2
-4,605
-100% -$1.14M ﹤0.01% 331
2021
Q3
$1.11M Sell
4,607
-786
-15% -$198K 0.99% 29
2021
Q2
$1.28M Buy
+5,393
New +$1.23M 1.07% 12
2020
Q2
Sell
-8,802
Closed -$956K 286
2020
Q1
$956K Buy
+8,802
New +$1.27M 0.61% 60

Other funds holding LH

USA Financial Formulas's LH Position: Q1 2026 in Review

USA Financial Formulas held its Labcorp (LH) position steady in Q1 2026 at 3 shares worth $800. The position accounts for ﹤0.01% of the portfolio, ranked #349.

USA Financial Formulas first reported a position in LH in Q1 2020 and has held it in 9 quarters since. The position peaked at $1.28M in Q2 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • USA Financial Formulas held 3 shares of Labcorp worth $800 as of Q1 2026.
  • USA Financial Formulas left its Labcorp share count unchanged in Q1 2026.
  • Labcorp made up ﹤0.01% of USA Financial Formulas's portfolio in Q1 2026, its #349 holding.
  • USA Financial Formulas first reported a position in Labcorp in Q1 2020 and has held it in 9 quarters since.
  • USA Financial Formulas's Labcorp position peaked at $1.28M in Q2 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on USA Financial Formulas's 13F filing for Q1 2026, filed 14 Apr 2026.